The Pangean Collective
Pangaea was built on decades of experience as seed producers and breeders of old-school genetics throughout the 2000s. We formed a collection of classics and blended them with vast array of imported clones.
Arriving in Israel in late 2020 in search of an R&D facility, we began collaborating with a group of highly skilled agronomists. Cloud9, in its early stages, had decided to develop their own proprietary strains. With their first varieties entering the Israeli medical market in 2018 and making lasting mark.
Over the years we have refined a series of exceptional varieties within a licensed research facility. Every batch, cross, hybrid, terpene, and cannabinoid profile has been carefully catalogued. Each selection was made with precision, chosen for its distinctive traits and developed to deliver outstanding results.
Our genetics are regularly released into medical markets, stocked in leading pharmacies and earning the trust of thousands of loyal patients.
Today, Pangea’s combined collection, services and varieties are available through specific licensing agreements.
Developed for medical markets and proven by cultivators.
Reliable.
Consistent.
Proven.
Contact us, enjoy the results.
